We are very excited today to announce a strategic collaboration with Bausch + Lomb to transform ophthalmology with precision medicine! Together, we aim to develop innovative treatments for age-related macular degeneration (AMD) by combining B+L's deep ophthalmology expertise with our AI-powered analytics platform. Read the full announcement: https://lnkd.in/eh2ppSAZ #CharacterBio #genomics #AMD #MacularDegeneration #PrecisionMedicine #biotech #ophthalmology #eyedisease #dryAMD #visionloss #AI #ArtificialIntelligence
Character Biosciences
生物技术
San Francisco，CA 5,250 位关注者
A patient-driven drug discovery platform for diseases of aging
关于我们
Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Our mission is to identify the genetic and molecular drivers of disease progression so we can develop targeted therapies for patients who urgently need them. We've built one of the most comprehensive resources in age-related eye diseases by partnering with over 150 ophthalmology clinics to integrate genetics with longitudinal clinical and imaging data. This deep phenotyping approach enables us to reclassify complex diseases like age-related macular degeneration (AMD) into genetically defined subtypes, unlocking novel therapeutic targets and optimizing patient selection for clinical trials. Character Bio’s AI-powered platform combines genomics, multi-modal data, and machine learning to discover and develop therapies that are more precise and more effective. Our lead programs, CTX114 and CTX203, are advancing toward clinical trials and are designed to slow or prevent vision loss in AMD patients. We are committed to delivering a new generation of precision medicines to treat and ultimately cure age-related blindness.
- 网站
-
https://www.characterbio.com
Character Biosciences的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- San Francisco，CA
- 类型
- 私人持股
- 创立
- 2019
地点
Character Biosciences员工
动态
-
We recently reached a significant milestone in our De-centralized Prospective Epidemiological Study of Progression of Age-related Macular Degeneration (AMD) Study by enrolling the first 5,000 patients! Upon reaching this important milestone, we shared with our study participants, research partners, and the general public updates and interim results. You can read those on our blog here: https://lnkd.in/etpyqPiN We thank each and every one of our participants for being a part of our mission to discover new treatments for AMD!
-
Welcome to the team Joe Davis! We are thrilled to announce that Dr. Joe Davis joins our team as Director of Data Science. Excited to see what you will accomplish!
-
-
We are thrilled to announce that Character Biosciences was selected to participate in Stanford University Graduate School of Business’s dy/dx program! Members of our management team have been in Palo Alto for the last three weeks learning from the incredible faculty and impressive cohort of founders and executives. Thank you to Stanford, Accel, Index Ventures, Lightspeed, Sequoia Capital, Innovation Endeavors for this transformative experience!
On Sunday we were overjoyed to welcome our third cohort of dy/dx at Stanford University Graduate School of Business with 53 leaders coming from 23 amazing startups! We have a diverse set of inspiring companies this year ranging from Seed to Series C and in various industries, from #gaming, to #robotics, to #petcare, and more, with of course a lot of #AI! A big thank you to our Venture Allies for continuing to support their founders through the dy/dx program! Accel, Index Ventures, Innovation Endeavors, Lightspeed, and Sequoia Capital #GSBExecEd #GSBdydx #startups
-
-
Happy Pride Month! At Character Biosciences, we recognize the invaluable contributions that LGBTQ+ scientists make in ophthalmology and all of STEM. To recognize LGBTQ+ scientists in STEM, Character Biosciences is giving back to Out in Science, Technology, Engineering & Mathematics (oSTEM), the largest chapter-based 501(c)(3) non-profit association dedicated to serving LGBTQ+ students and professionals around the world. ?We are proud to stand with the LGBTQ+ community and endeavor to build a vibrant and successful scientific community by embracing all individuals, regardless of sexual orientation or gender identity. Together we can create a society where everyone feels empowered to be their authentic selves, for Pride Month and beyond. Happy Pride Month from all of us at Character Bio!? #LGBTQinSTEM #PrideMonth “Science is a universal language that transcends borders, cultures, and identities. It thrives on diversity, inclusivity, and equality.” -Graduate Women in Science, LA chapter
-
Look forward to take part in ARVO next week, and proud to share some the exciting work from the Character Bio labs!
We're thrilled to announce that we'll be presenting at ARVO 2024! ?? We can't wait to connect with you and share our latest advancements. Catch us at the following presentations, and feel free to view their abstracts attached below: 1?? Poster B0216 - https://bit.ly/PosterB0216 2?? Poster B1009 - https://bit.ly/PosterB1009 3?? Presentation 6156 - https://lnkd.in/enhTMQKW #ARVO2024 #CharacterBio #AMD #VisionResearch #Ophthalmology
-
-
We're thrilled to announce that we'll be presenting at ARVO 2024! ?? We can't wait to connect with you and share our latest advancements. Catch us at the following presentations, and feel free to view their abstracts attached below: 1?? Poster B0216 - https://bit.ly/PosterB0216 2?? Poster B1009 - https://bit.ly/PosterB1009 3?? Presentation 6156 - https://lnkd.in/enhTMQKW #ARVO2024 #CharacterBio #AMD #VisionResearch #Ophthalmology
-